Briacell Therapeutics Corp (BCTX) — Cash Flow Reinvestment Rate

Latest as of April 2020: 0.00x

Briacell Therapeutics Corp (BCTX) has a Cash Flow Reinvestment Rate of 0.00x as of April 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $22.57K. See cash generation quality of Briacell Therapeutics Corp to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$22.57K
USD

Capital Expenditures

$0.00
USD

Briacell Therapeutics Corp Cash Flow Reinvestment Rate (2006–2006)

Historical reinvestment intensity for Briacell Therapeutics Corp across 1 annual periods. For the full cash flow conversion analysis, see Briacell Therapeutics Corp (BCTX) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for Briacell Therapeutics Corp (2006–2006)

Year-by-year capital reinvestment analysis for Briacell Therapeutics Corp. See financial flexibility index of Briacell Therapeutics Corp to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2006 0.00x $0.00 $1.13K $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow